…As ECOWAS seeks compensation for vaccine side effects, injury
The Presidency has addressed the concerns by Nigerians over President Muhammadu Buhari’s condition after taking the coronavirus vaccine on Saturday.
Vice President Yemi Osinbajo had also taken the vaccine, according to a statement by the Senior Special Assistant to the President on Media and Publicity, Mallam Garba Shehu.
The statement said both leaders are doing fine.
Shehu said in the statement that the clarification was in response to press enquiries inundating his office with the President’s health after the vaccine.
“I like to assure all citizens, and to dispel fears and misconceptions about the safety of the vaccine administered on President Muhammadu Buhari and the Vice President, Professor Yemi Osinbajo, SAN earlier this morning.
“After he got his jab, the President felt normal and went about doing his job. If there are side effects that follow, we will be open about that but so far there is nothing of a side effect, serious or mild on the President. He is carrying on as normal.
“We hope this will help to send a strong message among the people, especially those grappling with hesitancy about the efficacy and safety of the vaccine.”
Meanwhile, the Economic Community of West African States (ECOWAS) Vaccine Taskforce has recommended compensation for citizens who suffer side effects or injury from the COVID-19 vaccination.
The Director-General of the West African Health Organisation (WAHO), Prof. Stanley Okolo, who broke the news at the 5th Regional Steering Committee meeting of the Regional Disease Surveillance Systems Enhancement (REDISSE) project in Abuja yesterday, said that the recommendation was one of the resolutions adopted by the taskforce and presented to the ECOWAS Ministerial Coordinating Committee to encourage citizens to receive the vaccine.
The WAHO chief said: “Normally, vaccine development takes five years or even seven or eight years. Therefore, we have to think of how to share the indemnity if any problem develops.
“That is one of the issues now being taken up by COVAX, the global body set up by WHO, GAVI, to look at how they indemnify some of the companies regarding the vaccines they supplied.
“It is not so much as indemnify but making sure there are reasoned claims against the companies.
“In addition, member countries, whether in Africa, West Africa, Europe or Asia, have to think about the supplementary or residual indemnity for their people, and that’s one of the things the ECOWAS Vaccines Taskforce is discussing.
“We have already shared the issue with the 5th Ministerial Coordinating Committee and one of the resolutions is that member countries should watch out for any significant side effects or injury.
“We haven’t seen that yet in countries that are vaccinated widely, but member states should look to compensate affected citizens.”
Okolo explained that the objective of the Regional Steering Committee meeting was to assess the implementation of the REDISSE project, evaluate progress achieved toward meeting the objectives and make recommendations for enhanced implementation for greater results.
According to him, the implementation of the recommendations of the last Regional Steering Committee meeting held in Lome on November 2, 2019 will be assessed.
Some participants attended the meeting virtually due to the current surge of COVID-19 pandemic and the recent Ebola outbreak in Guinea.
The meeting took the form of a short presentation of the Technical Committee’s report, followed by discussions, summaries and recommendations, chaired by the WAHO Director General.